Novo Nordisk expects to appoint Dr Göran Ando as its new chairman next year after its existing chair Sten Scheibye was elected to the board of the Novo Nordisk Foundation.
Mr Scheibye is expected to become Chairman of the Foundation’s board in 2013 and has since become a non-independent director of the Novo Nordisk board.
The outgoing chair said Dr Ando has “impressed all of us with his expertise and insights” since he joined the leadership committee in 2005.
The experienced Dr Ando has been re-elected to Novo’s board of directors several times, most recently this year, during his seven year stay on the committee.
The 63-year-old has previously held senior positions at Pharmacia, now Pfizer, and at Glaxo. He has served as Vice Chairman of the Board since 2006.
“I am very pleased that Göran Ando is prepared to take over the chair in 2013 and thereby ensure a smooth transition,” said Sten Scheibye.
Sten Scheibye was first elected to the Novo board in 2003. He became vice chair a year later and was appointed Chairman in 2006.
Share this article: